Skip to content

Compression therapies for the treatment of venous leg ulcers

A randomised controlled trial of compression therapies for the treatment of venous leg ulcers (VenUS 6)

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ISRCTN
Registry ID
ISRCTN67321719
Enrollment
675
Registered
2020-09-14
Start date
2020-10-01
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Venous leg ulcers Circulatory System Venous ulcers

Interventions

Current interventions as of 09/02/2024: The study has a 45-month recruitment period in total (comprising and initial 32 month planned recruitment period plus 13 month extension) including an initial 6

Sponsors

Manchester University NHS Foundation Trust
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 110 Years

Inclusion criteria

Inclusion criteria: 1. =1 venous leg ulcer 2. Ankle:brachial pressure index (ABPI) =0. 8 (taken within the previous 3 months or where an ABPI is not viable, use of locally-approved alternative assessments to rule out peripheral arterial disease i.e. pulse palpation and doppler ausculation toe pressure assessment or arterial imaging also taken within the last 3 months) 3. Able to tolerate full compression 4. Aged =18 years

Exclusion criteria

Exclusion criteria: 1. Unwilling to wear full compression 2. Leg ulcers of non-venous aetiology (e.g. arterial or rheumatoid) 3. significant peripheral vascular disease which contraindicates full compression ( requiring an APBI of at least 0.8) 4. Ulcers confined to the foot 5. Lacks capacity or willingness to provide consent to participate in the trial 6. Currently participating in another study evaluating treatments for their venous leg ulcer 7. Known allergy to any trial product 8. Previously recruited for this trial 9. Deemed to be not clinically appropriate to take part in the trial (at clinician discretion) 10. On a waiting list for endovenous ablation and is expected to have surgery within 28 days Added 27/08/2021: 10. Planned treatment to close/remove incompetent superficial veins (e.g. via endovenous ablation, sclerotherapy) within 28 days

Design outcomes

Primary

MeasureTime frame
Time to healing of the reference ulcer, defined as 'complete epithelial cover in the absence of a scab with no dressing required. This will be measured by blinded assessment (by two independent blinded assessors, and where there is any disagreement in review, a third review may be completed) of digital images taken at baseline and when the treating nurse regards the reference ulcer as healed

Secondary

MeasureTime frame
1. Health-related quality of life measured using the VEnous INsufficiency Epidemiological and Economic Study - Quality of Life (VEINES-QOL) and the EuroQol 5-dimension 5-level quality of life questionnaire (EQ-5D-5L) at baseline, 1, 3, 6, and 12 months 2. Resource use measured using a set of questions recording the ulcer-related care from the NHS within the past 3 months at 3, 6, and 12 months 3. Wound-related pain measured using the Visual Analogue Pain Scale (VAS) at baseline, 1, 3, 6, and 12 months 4. Participant adherence and ease of treatment use measured using a set of questions assessing views on the compression treatments, volume of treatment use, and reasons for reduced dose at 1, 3, 6 and 12 months 5. Incidence of clinical events such as reference leg healing, ulcer recurrence, amputation, admission, and discharge or death will also be recorded if and when they occur

Countries

England, United Kingdom

Contacts

Public ContactCatherine Arundel
Catherine.arundel@york.ac.uk+44 (0)1904 321 116

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Aug 9, 2026